Opioid and Non-Opioid Medications Management: Filling in the Gaps, Prescribing for the Whole Patient

Opioid and Non-Opioid Medications Management: Filling in the Gaps, Prescribing for the Whole Patient is organized by American Academy of Pain Medicine (AAPM) and will be held from Aug 17, 2016 - Aug 17, 2019.

Accreditation:
The American Academy of Pain Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation:
The American Academy of Pain Medicine designates this enduring material activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Opioid Management and Controversies 
.75 credits - Opioid Management (intro) and Opioid Pharmacology (running time 38:23)
.5 credits - Abuse Deterrent Opioid Formulations: What Prescribers Need to Know (running time 34:52)
.25 credits - Medically Directed Opioid Tapering: When, Where & How (running time 21:59)
.25 credits - Adverse Effects of Opioids (running time 23:34)
.5 credits - Opioid-Induced Hyperalgesia: Does it Really Exist? (running time 24:50) 
.5 credits - Methadone: What Physicians Need to Know (running time 28:37) 
1.0 credit - Integrating Recent Guidelines into Clinical Practice (running time 1:06:10) 
.75 credits - Addiction Medication Primer: Opioid Use Disorders - Neurobiology and Pharmacotherapy (running time 44:29) 
.75 credits - The Changing Landscape of Prescription Opioid Abuse in the United States (running time 40:42) 

Opioid Induced Constipation (OIC) 
.25 credits - OIC: A Consensus Definition and Its Clinical Implications (running time 20:05)
.25 credits - Clinical Considerations Related to When to Choose a Prescription Therapy for OIC (running time 15:10) 
.5 credits - Opioid-induced Constipation: Options for Improving Assessment and Management (running time 35:15)

Non-Opioid Analgesics and Agents
.75 credits - Pharmacologic Neuropathic Pain Treatment: Anticonvulsants (running time 47:26)
.75 credits - Psychiatric Medication Primer for the Pain Clinician: Depression and Anxiety (running time 40:45) 
.5 credits - Topical Analgesics (running time 33:03)
.25 credits - Muscle Relaxers: Review of Agents and Evidence (running time 15:45)

Other Pain Conditions
.75 credits - Headache Medications (running time 40:11) 
.75 credits - Insomnia: Medication Approaches (running time 38:52) 

Target Audience & Educational Design:
The pharmacologic management of chronic pain is an important aspect of clinical practice in the primary care setting. However, strategies aimed at optimizing the use of non-opioid analgesics while mitigating the potential risks associated with opioid use can be difficult to implement in daily clinical practice. The focus of this enduring course is to provide useful, practical information about the use of opioid and non-opioid analgesics to improve the effective pharmacologic management of adults with chronic pain in the primary care setting.This enduring activity consisting of video lectures accompanied by slides is designed for all practitioners seeking to improve their knowledge of pharmaceutical control of chronic pain.

Educational Objectives:
After completing this enduring activity, the learner should be better able to…
• Review complexities and gain insights into the recent epidemiological evidence related to substance abuse and misuse, an opioid analgesic, and heroin overdose deaths, and the growing problem of benzodiazepines use by recreational uses, drug abusers, and patients suffering from chronic pain
• Review the opioid pharmacologic agents and understand potential benefits and short-comings of the evolving abuse-deterrent formulations
• Assess for and interpret aberrant drug-related behaviors, integrate risk assessment tools, and risk management strategies into clinical practice as a means to improving and identifying appropriate patients for ongoing opioid management and identifying those patients not benefiting and/or need to be weaned or detoxified
• Apply greater knowledge of more comprehensive assessment of sleep disorders in chronic pain patients and pharmacologic options that may be used to help patients
• Review NSAID pharmacology for oral and topical formulations examine the evidence for these agents related to analgesic efficacy as well as potential adverse events including renal, cardiac, gastrointestinal toxicities, and death.
• Define the unique pharmacologic properties and toxicities of methadone while utilizing recommended evidence-based practices when prescribing methadone.
• Define opioid-induced constipation, screening tools that can be used to better assess this condition, and know when a prescriptive therapy for opioid-induced constipation should be considered.

Additional details will be posted as soon as they are available.